Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Ehrenstein

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.
The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.
Rheumatology Advances in Practice|March 12, 2024
Differences in management approaches for lupus nephritis within the UKSara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, et al.
Frontiers in Immunology|May 19, 2018
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGITRose M Gilbert, Xiaozhe Zhang, Robert D Sampson, et al.
The Journal of Experimental Medicine|February 20, 2013
Germinal center B cells govern their own fate via antibody feedbackYang Zhang, Michael Meyer-Hermann, Laura A George, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Internal Medicine|October 26, 2021
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled TrialMuhammad Shipa, Andrew Embleton-Thirsk, Mariea Parvaz, et al.
The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.
Rheumatology Advances in Practice|March 12, 2024
Differences in management approaches for lupus nephritis within the UKSara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, et al.
Frontiers in Immunology|May 19, 2018
Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGITRose M Gilbert, Xiaozhe Zhang, Robert D Sampson, et al.
The Journal of Experimental Medicine|February 20, 2013
Germinal center B cells govern their own fate via antibody feedbackYang Zhang, Michael Meyer-Hermann, Laura A George, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
Pageof 7